title: A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
authors.affiliation: Department of Neurology, UCLA School of Medicine.
authors.forename: W W
authors.initials: WW
authors.lastname: Tourtellotte
authors.forename: K
authors.initials: K
authors.lastname: Syndulko
authors.forename: R W
authors.initials: RW
authors.lastname: Baumhefner
authors.forename: P
authors.initials: P
authors.lastname: Shapshak
authors.forename: M
authors.initials: M
authors.lastname: Osborne
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000917:Antibody Formation; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007165:Immunosuppression Therapy; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D012107:Research Design
chemical_list: D000305:Adrenal Cortex Hormones; D007074:Immunoglobulin G; D001379:Azathioprine